Authors

1. Earhart, Ann MSN, ACNS-BC, CRNI(R)
2. McMahon, Paula BS, RN, CRNI(R), CRN

Abstract

Over the past several years, the Food and Drug Administration (FDA) has received more than 250 adverse event reports in which vascular access devices have ruptured when used with power injectors. The adverse events include rupture and device fragmentation. The outcome of these events affects both the patient and the care provider.